Acquiring Company
Accord Healthcare
Acquired Company
Prothya Biosolutions
Description
Accord Plasma B.V. has completed the acquisition of Prothya Biosolutions Belgium BV and its subsidiaries. This acquisition enhances Accord's global capabilities in plasma-derived medicines. It combines Prothya’s expertise in Europe with Intas’s infrastructure in India. The move aims to improve access to essential plasma therapies for patients worldwide.
Quick answer
Accord Healthcare is acquiring Prothya Biosolutions, announced October 20, 2025.
- How much did Accord Healthcare pay for Prothya Biosolutions?
- The deal value was not disclosed.
- What does Accord Healthcare do?
- Accord Healthcare is an award-winning pharmaceutical company driven to thinking differently so that more patients around the world have access to the essential and affordable medicines that they need.
- Who are the decision-makers at Accord Healthcare?
- Fundz holds 1 contact at Accord Healthcare. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- AbbVie acquires Bretisilocin for mental health expansion (October 15, 2025)
- MannKind acquires scPharmaceuticals to boost growth (October 7, 2025)
- Avanos Medical acquires Nexus Medical for growth (September 15, 2025)
- Day One to acquire Mersana for $130 million, $130M (November 30, 2025)
- XOMA Royalty acquires LAVA Therapeutics N.V. (November 21, 2025)
- ClearPoint Neuro acquires IRRAS for $5 million, $5M (November 20, 2025)
Who to call at Accord Healthcare, and when
When Accord Healthcare changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Accord Healthcare raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Accord Healthcare, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Accord Healthcare. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Accord Healthcare makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Prothya Biosolutions?
Prothya Biosolutions was acquired by Accord Healthcare. The deal was reported on October 20, 2025. Accord Healthcare is an award-winning pharmaceutical company driven to thinking differently so that more patients around the world have access to the essential and affordable medicines that they need. Accord Healthcare is privately held and operates in Biotechnology.
When did Accord Healthcare acquire Prothya Biosolutions?
Accord Healthcare's acquisition of Prothya Biosolutions was reported on October 20, 2025. Accord Plasma B.V. has completed the acquisition of Prothya Biosolutions Belgium BV and its subsidiaries. This acquisition enhances Accord's global capabilities in plasma-derived medicines. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Prothya Biosolutions do?
Prothya Biosolutions is a leading plasma-derived medicinal products business based primarily in the Netherlands and Belgium. It employs approximately 1,200 people and is one of Europe's largest plasma fractionators. It is privately held, operating in Manufacturing.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.